These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20091489)

  • 61. Naturally occurring structural isomers in serum IgA1 o-glycosylation.
    Takahashi K; Smith AD; Poulsen K; Kilian M; Julian BA; Mestecky J; Novak J; Renfrow MB
    J Proteome Res; 2012 Feb; 11(2):692-702. PubMed ID: 22067045
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
    Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
    Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy.
    Hiki Y; Iwase H; Saitoh M; Saitoh Y; Horii A; Hotta K; Kobayashi Y
    Nephron; 1996; 72(3):429-35. PubMed ID: 8852492
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants.
    Zhang S; Sun H; Zhang Z; Li M; Guo Z; Ye W; Cai G; Sun W; Li M
    Front Mol Biosci; 2022; 9():871615. PubMed ID: 35445079
    [No Abstract]   [Full Text] [Related]  

  • 65. [Binding of IgA1 to monocyte/macrophage cell lines (THP-1, U937) in IgA nephropathy--a possible role of O-glycan in the IgA1 molecule].
    Horii A; Hiki Y; Saitoh M; Kanamori A; Iwase H; Hotta K; Kobayashi Y
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):558-63. PubMed ID: 7474508
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes.
    Nakamura I; Iwase H; Arai K; Nagai Y; Toma K; Katsumata T; Hiki Y; Kokubo T; Sano T; Kobayashi Y
    Nephrology (Carlton); 2004 Feb; 9(1):26-30. PubMed ID: 14996305
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based Glycoproteomics.
    Hinneburg H; Stavenhagen K; Schweiger-Hufnagel U; Pengelley S; Jabs W; Seeberger PH; Silva DV; Wuhrer M; Kolarich D
    J Am Soc Mass Spectrom; 2016 Mar; 27(3):507-19. PubMed ID: 26729457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide.
    Iwase H; Tanaka A; Hiki Y; Kokubo T; Ishii-Karakasa I; Kobayashi Y; Hotta K
    J Biochem; 1996 Aug; 120(2):393-7. PubMed ID: 8889826
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy.
    Allen AC; Topham PS; Harper SJ; Feehally J
    Nephrol Dial Transplant; 1997 Apr; 12(4):701-6. PubMed ID: 9140997
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterogeneity of O-glycosylation in the hinge region of human IgA1.
    Novak J; Tomana M; Kilian M; Coward L; Kulhavy R; Barnes S; Mestecky J
    Mol Immunol; 2000 Dec; 37(17):1047-56. PubMed ID: 11399322
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TLR9 and BAFF: their expression in patients with IgA nephropathy.
    Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
    Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
    Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
    Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
    van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
    Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy.
    Kokubo T; Hiki Y; Iwase H; Horii A; Tanaka A; Nishikido J; Hotta K; Kobayashi Y
    J Am Soc Nephrol; 1997 Jun; 8(6):915-9. PubMed ID: 9189858
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
    Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
    Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy.
    Qi YY; Zhou XJ; Cheng FJ; Zhang H
    Dis Markers; 2016; 2016():8123138. PubMed ID: 27563166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Feasibility of peptide mass fingerprinting for differential diagnosis of IgA and non-IgA nephropathy].
    Gao J; Wang Y; Wen XY; Lu HH; Dong ZN; Tian YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1309-13. PubMed ID: 21868311
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion.
    Iwase H; Tanaka A; Hiki Y; Kokubo T; Sano T; Ishii-Karakasa I; Toma K; Kobayashi Y; Hotta K
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):1-7. PubMed ID: 10202952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative determination of human IgA subclasses and their Fc-glycosylation patterns in plasma by using a peptide analogue internal standard and ultra-high-performance liquid chromatography/triple quadrupole mass spectrometry.
    Chen HF; Shiao CY; Wu MY; Lin YC; Chen HH; Chang WC; Wu MS; Kao CC; Tsai IL
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8606. PubMed ID: 31705576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides.
    Bondt A; Nicolardi S; Jansen BC; Stavenhagen K; Blank D; Kammeijer GS; Kozak RP; Fernandes DL; Hensbergen PJ; Hazes JM; van der Burgt YE; Dolhain RJ; Wuhrer M
    Sci Rep; 2016 Jun; 6():27955. PubMed ID: 27302155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.